BO ZHUO TRADE (HONG KONG )LIMITED – Trademark Portfolio

Entity Type: 99

BO ZHUO TRADE (HONG KONG )LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include REVONS, WONIEX, and COCENBO. The owner is based in HONG KONG.

FLAT/RM B 5/F GAYLORD COMM BLDG

114-118 LOCKHART RD

HONG KONG 999077 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WONIEX
WONIEX
Registered 2023
COCENBO
COCENBO
Registered 2021
REVONS
REVONS
Registered 2020
WONIEX
WONIEX
Registered 2020

Trademark Classifications

BO ZHUO TRADE (HONG KONG )LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BO ZHUO TRADE (HONG KONG )LIMITED have?

BO ZHUO TRADE (HONG KONG )LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does BO ZHUO TRADE (HONG KONG )LIMITED file in?

BO ZHUO TRADE (HONG KONG )LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BO ZHUO TRADE (HONG KONG )LIMITED's most well-known trademarks?

BO ZHUO TRADE (HONG KONG )LIMITED's registered trademark portfolio includes well-known marks such as REVONS, WONIEX, and COCENBO. These are among 4 currently registered trademarks in the portfolio.

What is BO ZHUO TRADE (HONG KONG )LIMITED's trademark registration success rate?

BO ZHUO TRADE (HONG KONG )LIMITED has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.